Trial intelligence / Profile preview

Imaging Brain Energy Use in Cocaine Use Disorder

NCT07773649Phase 1Recruiting

Start
Sep 2026
Primary completion
Dec 2029
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of [18F]BCPP-EF in cocaine use disorder (CUD). Primary endpoints: Orbitofrontal Cortex [F-18]BCPP-EF Volume of Distribution, Midbrain [F-18]BCPP-EF Volume of Distribution and 1 more. Started Sep 2026; status: recruiting.

02

Drugs

[18F]BCPP-EF
03

Conditions

cocaine use disorder (CUD)

Beyond the preview

Go deeper on NCT07773649.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07773649.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call